Bio Pharma Dive
SEPTEMBER 14, 2020
Merck's deal for Seattle Genetics' antibody-drug conjugate comes as Gilead agreed to acquire rival developer Immunomedics in the biotech industry's largest buyout of 2020.
World of DTC Marketing
SEPTEMBER 14, 2020
THE BASICS: A “critical part” of pharmaceutical company AbbVie ‘s success is “face-to-face” interaction, CEO Richard Gonzalez explained in an Aug. 27 email outlining its process for bringing thousands of U.S.-based employees back to work. This is beyond irresponsible. According to CNBC “AbbVie workers say they worry that the company is putting profits ahead of safety and the health of its U.S. employees and their families at risk.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
SEPTEMBER 14, 2020
The benefit of adding Lilly's Olumiant to Gilead's antiviral Veklury appeared modest, reducing time to recovery by one day in a study of hospitalized patients.
BioSpace
SEPTEMBER 14, 2020
In a weekend interview on CBS’ “Face the Nation,” Albert Bourla, chief executive officer of Pfizer indicated they may have key data from its Phase III trial of the vaccine to the U.S. Food and Drug Administration by the end of October.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
XTalks
SEPTEMBER 14, 2020
Falls and fractures due to poor bone metabolism are a growing concern as the population ages. In fact, one-third of all fall-related deaths are attributed to low bone density, a condition that impacts 200 million women globally. At the same time, 31% of global mortality is attributed to impaired cardiovascular health. Have you ever considered that bone and heart health are integrally linked?
Pharma Marketing Network
SEPTEMBER 14, 2020
Fast-tracking digital communication is now the new normal across many industries. The healthcare industry is no exception, and for pharma sales reps engaging with healthcare professionals, human connection is key. But today, communication between your reps and HCPs may be limited, or even embargoed altogether. Yet there are still a number of opportunities for engagement, and using video is one that offers various ways to maintain these connections.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
BioSpace
SEPTEMBER 14, 2020
AstraZeneca resumed its vaccine testing in the United Kingdom following confirmation from the Medicines Health Regulatory Authority (MHRA) that it was safe to do so.
Scienmag
SEPTEMBER 14, 2020
Credit: Photo by Sophie McCoy. FSU Assistant Professor of Biological Science Sophie McCoy and her team are proposing formal definitions for algae species and subcategories for the research community to consider: They are recommending algae be classified first by DNA and then by other traits. The work, which includes collaborations with Stacy Krueger-Hadfield, assistant professor […].
BioSpace
SEPTEMBER 14, 2020
The deal, announced Sunday, has been unanimously approved by the boards of directors of both companies.
Scienmag
SEPTEMBER 14, 2020
Credit: Penn Nursing The United States has seen a 200% increase in the rate of deaths by opioid overdose in the last 20 years. But many of these deaths were preventable. Naloxone, also called Narcan, is a prescription drug that reverses opioid overdoses, and in more than 40 states — including Pennsylvania — there is […].
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
BioPharma Reporter
SEPTEMBER 14, 2020
Pfizer and BioNTech plan to expand the enrolment of their Phase 3 COVID-19 trial to up to 44,000 participants: which will also include new populations.
Scienmag
SEPTEMBER 14, 2020
Credit: Center for Global Health Science and Security at Georgetown University Medical Center WASHINGTON (Sept. 14, 2020) — In a new report commissioned by the Global Preparedness Monitoring Board (GPMB), Georgetown global health experts say the success of any effort to redress pandemic preparedness failures demonstrated by COVID-19 requires a re-centering of governance that would […].
XTalks
SEPTEMBER 14, 2020
Aluminum is a popular choice for food packaging because of its superior recyclability and unique properties for product brands over other materials like plastics and glass – it is endlessly recyclable compared to plastic and paper, while being lighter and studier than glass. It is one of the world’s most flexible and versatile elements: easy to shape, stable and resistant to organic acids, and a good conductor of electricity and heat.
BioSpace
SEPTEMBER 14, 2020
When biotech companies consider conducting business in China, their concerns are radically different than they were even four years ago.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
XTalks
SEPTEMBER 14, 2020
The pandemic has forced food and beverage companies to think outside the box to weather the storm of uncertainty and stay afloat. But some are taking it too far, using the pandemic to ingratiate themselves with the public and government, a new report from the NCD (non-communicable disease) Alliance and SPECTRUM Consortium found. The report concluded that unhealthy commodity companies around the world, including alcohol, tobacco and junk foods, are leveraging the COVID-19 pandemic for commercial
Pharma Times
SEPTEMBER 14, 2020
The move adds Trodelvy, a first-in-class antibody-drug conjugate approved to treat triple-negative breast cancer, to the drugmaker's portfolio
BioSpace
SEPTEMBER 14, 2020
Grail, a spin out of genome sequencing firm Illumina, filed a preliminary prospectus for a $100 million initial public offering (IPO) last week with the U.S. Securities and Exchange Commission (SEC).
Pharma Times
SEPTEMBER 14, 2020
Under the deal the UK and Japan will incorporate functions of the existing EU/Japan Mutual Recognition Agreement for medicines
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Scienmag
SEPTEMBER 14, 2020
UTA civil engineer using recycled plastic pins to stabilize bridges and highway slopes Credit: UT Arlington A civil engineering professor at The University of Texas at Arlington has received a two-year, $987,140 contract from the Texas Department of Transportation (TxDOT) to investigate the use of recycled plastic pins to repair deep-seated failures on embankments and […].
Pharma Marketing Network
SEPTEMBER 14, 2020
Fast-tracking digital communication is now the new normal across many industries. The healthcare industry is no exception, and for pharma sales reps engaging with healthcare professionals, human connection is key. But today, communication between your reps and HCPs may be limited, or even embargoed altogether. Yet there are still a number of opportunities for engagement, and using video is one that offers various ways to maintain these connections.
Scienmag
SEPTEMBER 14, 2020
Passive monitoring of phone usage shows emotional state of mind Credit: Jeremy Huckins. HANOVER, N.H. – September 14, 2020 – Information on social activity, screen time and location from smartphones can predict connectivity between regions of the brain that are responsible for emotion, according to a study from Dartmouth College. In the research, data from […].
BioSpace
SEPTEMBER 14, 2020
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 14, 2020.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Scienmag
SEPTEMBER 14, 2020
Appointing a new leader just before an election leads to a higher turnover of MPs after the poll, a study of political parties across Europe during the past 80 years shows. A change at the top is a key determinant of how many politicians will step down and be re-elected, experts who have analysed hundreds […].
BioPharma Reporter
SEPTEMBER 14, 2020
Merck and Seattle Genetics have announced two strategic oncology collaborations: one to develop Seattle Geneticsâ antibody-drug conjugate ladiratuzumab vedotin worldwide; and another to accelerate the global reach of Tukysa (tucatinib).
BioSpace
SEPTEMBER 14, 2020
Merck is making a major investment into Bothwell, Washington-based Seattle Genetics with two strategic oncology deals.
Pharma Times
SEPTEMBER 14, 2020
The Institute has endorsed the drug for first-line treatment of adults with locally-advanced or EGFR mutation-positive NSCLC
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
BioSpace
SEPTEMBER 14, 2020
It was a busy week for clinical trial updates. Here’s a look.
Scienmag
SEPTEMBER 14, 2020
Credit: RUDN Univeristy A group of medical and environmental researchers from RUDN University evaluated the level of heavy metals in the organism of first-year university students from different countries of the world. The results of the screening helped the scientists to reveal a relationship between a region of residence and the level of toxic metal […].
XTalks
SEPTEMBER 14, 2020
The plant-based milk industry is estimated to rise at a steady CAGR of 4.5 percent by 2030. The plant-based industry, which includes meat and dairy alternatives, is a sector that is growing at an unprecedented rate, and the level of competition and disruption in the industry is high. Plant-based products have evolved to be the perfect substitutes for animal-based products.
Scienmag
SEPTEMBER 14, 2020
Credit: Image courtesy: Tong Wang Imagine harnessing evaporation as a source of energy or developing next generation actuators and artificial muscles for a broad array of applications. These are the new possibilities with the creation by an international team of researchers, led by The City College of New York’s Xi Chen and his co-authors at […].
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
297 
Let's personalize your content